Precision Biosciences INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NASDAQ
Precision BioSciences, Inc. has issued its proxy statement for the 2026 Annual Meeting of Stockholders, scheduled for May 21, 2026, detailing proposals including director elections, auditor ratification, executive compensation, and equity plan amendments.
NASDAQ
Precision BioSciences has filed a definitive proxy statement with the SEC, signaling upcoming shareholder actions.
NASDAQ
Precision BioSciences will hold its 2025 annual meeting of stockholders on May 28, 2025, via a virtual webcast.
NASDAQ
Precision BioSciences has filed a definitive proxy statement with the SEC.
NASDAQ
DEF 14A: Precision BioSciences Sets Date for 2024 Annual Stockholders Meeting, Outlines Key Proposals
Precision BioSciences announces its 2024 annual meeting of stockholders to be held virtually on June 4, 2024, outlining proposals for director elections, auditor ratification, incentive plan amendments, and potential meeting adjournment.